Axon Drugs Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 1990.
1990 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Axon Drugs Private Limited

Axon Drugs Private Limited, a active private limited company, was established on 10 July 1990 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24117TN1990PTC019380. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹2.00 Cr and a paid-up capital of ₹2.00 Cr.

Formerly known as Alsalabs Pvt Ltd. It upholds a compliant status. Employing 53 professional, Its leadership includes Pushpakala Harirajan (Whole-Time Director), Vikram Harirajan (Director), Damodaram Harirajan (Managing Director). Past directors included Shanthamohan Anbil Rajmohan, Mittalal Surajmal, Pushpakala Harirajan. It holds ₹14.21 Cr open charges and ₹5.69 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.14, Santhosh Nagar, Korattur North, Chennai, Tamil Nadu, 600076.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24117TN1990PTC019380

  • Registration Number

    019380

  • Incorporation Date

    10 July 1990

  • Authorized Capital

    ₹2.00 Cr

  • Paid-Up Capital

    ₹2.00 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 2.00 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 35 Year, 7 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 14.21 Cr
  • Satisfied Charges ₹ 5.69 M
  • Revenue Growth **** 3.71%
  • Profit Growth **** 91.12%
  • Ebitda **** 46.88%
  • Net Worth 16.24%
  • Total Assets **** 9.10%
Company report

Axon Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Axon Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Axon Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Pushpakala Harirajan Whole-Time Director 10 Jul 1990 Current
Vikram Harirajan Director 14 Aug 2008 Current
Damodaram Harirajan Managing Director 10 Jul 1990 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 Aug 2008 Past
Pramod Abcsdd Director 18 Jul 2020 Past
Pramod Abcsdd Director 31 Mar 2023 Past
Pramod Abcsdd Director 31 Mar 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Axon Drugs.

Axon Drugs Private Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 3.71% increase. The company also saw a substantial improvement in profitability, with a 91.12% increase in profit. The company's net worth Soared by an impressive increase of 16.24%.

Axon Drugs revenue growth over time
Axon Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 3.71%
*******
*******
*******
*******
Revenue from Operations
*******
 4.20%
*******
*******
*******
*******
Total Assets
*******
 9.10%
*******
*******
*******
*******
Profit or Loss
*******
 91.12%
*******
*******
*******
*******
Net Worth
*******
 16.24%
*******
*******
*******
*******
EBITDA
*******
 46.88%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Axon Drugs?

In 2024, Axon Drugs had a public holding of 8.51%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹142,145,000.00

Satisfied Charges

₹5,688,800.00

Charges Breakdown by Lending Institutions
  • Indian Overseas Bank : 14.09 Cr
  • Indian Overaseas Bank : 0.12 Cr
Latest Charge Details
Date Lender Amount Status
22 Jul 2013 Indian Overseas Bank ₹10.00 Cr Open
28 Feb 2000 Indian Overseas Bank ₹4.30 M Open
07 Oct 1999 Indian Overseas Bank ₹0.40 M Open
21 Mar 1997 Indian Overseas Bank ₹0.50 M Open
24 Jul 1992 Indian Overaseas Bank ₹0.70 M Open

Explore comprehensive loan charge details -

How Many Employees Work at Axon Drugs?

Axon Drugs has a workforce of 53 employees as of Feb 27, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Axon Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Axon Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Axon Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Axon Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Axon Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was recorded as a recent event.

  • Charges

    The activity A charge with Indian Overseas Bank of Rs. 3.57 Cr registered on 18 Jul 1992 with Charge ID 90290048 was modified on 12 Jan 2024. was completed.

  • Charges

    Progress on A charge with Indian Overseas Bank amounted to Rs. 10.00 Cr with Charge ID 10439382 was registered on 22 Jul 2013. was documented.

  • Director Appointment

    Progress on Vikram Harirajan was appointed as a Director was appointed as a Director on 14 Aug 2008 & has been associated with this company since 17 years 6 months . was documented.

  • Charges

    The activity A charge registered on 26 Jul 2002 via Charge ID 90301095 with Tamil Nadu Industrial Investment Corporation Limited was fully satisfied on 28 Aug 2007. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Axon Drugs Private Limited?

The CIN of Axon Drugs Private Limited is U24117TN1990PTC019380.

Where is Axon Drugs Private Limited headquartered?

Axon Drugs Private Limited is headquartered at Plot No.14, Santhosh Nagar, Korattur North, Chennai, Tamil Nadu, 600076.

When was Axon Drugs Private Limited incorporated?

Axon Drugs Private Limited was incorporated on 10 July 1990.

Who are the current directors of Axon Drugs Private Limited?

The current directors of Axon Drugs Private Limited are

What is the primary industry of Axon Drugs Private Limited?

The primary industry of Axon Drugs Private Limited is Manufacturing.

Is Axon Drugs Private Limited a listed company?

Axon Drugs Private Limited is unlisted.

What is the capital structure of Axon Drugs Private Limited?

The authorized capital of Axon Drugs Private Limited is ₹2.00 Cr, and the paid-up capital is ₹2.00 Cr.

What is the compliance status of Axon Drugs Private Limited?

The compliance status of Axon Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available